This pathway, along with the mTOR axis, is usually coactivated in BRAF mutations, which induces the vascular endothelial growth factor receptors (VEGFR) and platelet-derived growth factor receptors (PDGFR); these receptors are crucial in sustaining the tumor growth [37]. The gene discussed is BRAF; the disease is neoplasm.